Abeda Jamadar
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
Papers in
-
- Renal and related cancers 5
- FOXO transcription factor regulation 1
- Genetics 5
- Genetic and Kidney Cyst Diseases 4
- Co-authors
- Subhash Padhyé (5 shared papers)Reena Rao (8 shared papers)Fazlul H. Sarkar (3 shared papers)Sanjeev Banerjee (2 shared papers)Prasad Dandawate (2 shared papers)Alok Vyas (2 shared papers)Aamir Ahmad (2 shared papers)Timothy A. Fields (4 shared papers)
- Journals
- Pharmaceutical Research (2 papers)Journal of the American Society of Nephrology (2 papers)Cell Death and Disease (1 paper)Kidney International (1 paper)Dalton Transactions (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Abeda Jamadar
14 papers receiving 406 citations
Peers
Comparison fields: 5 of 76
- Molecular Medicine 102
- Pharmaceutical Science 36
- Toxicology 15
- Nephrology 30
- Biomaterials 53
Countries citing papers authored by Abeda Jamadar
This map shows the geographic impact of Abeda Jamadar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abeda Jamadar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abeda Jamadar more than expected).
Fields of papers citing papers by Abeda Jamadar
This network shows the impact of papers produced by Abeda Jamadar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abeda Jamadar. The network helps show where Abeda Jamadar may publish in the future.
Co-authors
The 25 scholars most cited alongside Abeda Jamadar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 110 | |
| 2 | 2009 | 98 | |
| 3 | 2012 | 39 | |
| 4 | 2019 | 32 | |
| 5 | 2021 | 32 | |
| 6 | 2020 | 24 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 15 | |
| 9 | 2022 | 11 | |
| 10 | 2007 | 9 | |
| 11 | 2012 | 8 | |
| 12 | 2022 | 6 | |
| 13 | 2024 | 1 | |
| 14 | Anti-cancer potential of natural products containing (6H-dibenzo[b,d]pyran-6-one) framework using docking tools. | 2021 | 1 |
About Abeda Jamadar
Abeda Jamadar is a scholar working on Molecular Biology, Genetics, Molecular Medicine, Cell Biology and Organic Chemistry, having authored 14 papers that have together received 409 indexed citations. Recurring topics across this work include Renal and related cancers (5 papers), Genetic and Kidney Cyst Diseases (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Curcumin's Biomedical Applications (3 papers), Computational Drug Discovery Methods (2 papers), Metal complexes synthesis and properties (2 papers), Drug Solubulity and Delivery Systems (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Molecular Medicine (102 citations), Pharmaceutical Science (36 citations), Toxicology (15 citations), Nephrology (30 citations) and Biomaterials (53 citations). Abeda Jamadar has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Subhash Padhyé, Reena Rao, Fazlul H. Sarkar, Sanjeev Banerjee, Prasad Dandawate, Alok Vyas, Aamir Ahmad, Timothy A. Fields, Jyoti Deshpande and Nidhi Dwivedi. Their work appears in journals such as Pharmaceutical Research, Journal of the American Society of Nephrology, Cell Death and Disease, Kidney International and Dalton Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.